BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16454038)

  • 1. Nested multigene MSP/DHPLC method for analyzing promoter hypermethylation status in clinical samples.
    Divine KK; Liechty KC; Crume KC; Belinsky SA
    Biotechniques; 2006 Jan; 40(1):40, 42, 44 passim. PubMed ID: 16454038
    [No Abstract]   [Full Text] [Related]  

  • 2. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.
    Rosas SL; Koch W; da Costa Carvalho MG; Wu L; Califano J; Westra W; Jen J; Sidransky D
    Cancer Res; 2001 Feb; 61(3):939-42. PubMed ID: 11221887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.
    Kim DH; Nelson HH; Wiencke JK; Zheng S; Christiani DC; Wain JC; Mark EJ; Kelsey KT
    Cancer Res; 2001 Apr; 61(8):3419-24. PubMed ID: 11309302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers.
    Yanagawa N; Tamura G; Oizumi H; Takahashi N; Shimazaki Y; Motoyama T
    Cancer Sci; 2003 Jul; 94(7):589-92. PubMed ID: 12841866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage.
    Chan EC; Lam SY; Tsang KW; Lam B; Ho JC; Fu KH; Lam WK; Kwong YL
    Clin Cancer Res; 2002 Dec; 8(12):3741-6. PubMed ID: 12473584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray.
    Wang Y; Zhang D; Zheng W; Luo J; Bai Y; Lu Z
    Cancer; 2008 Mar; 112(6):1325-36. PubMed ID: 18286531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
    Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
    Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent intra-tumoural heterogeneity of promoter hypermethylation in malignant melanoma.
    Rastetter M; Schagdarsurengin U; Lahtz C; Fiedler E; Marsch WCh; Dammann R; Helmbold P
    Histol Histopathol; 2007 Sep; 22(9):1005-15. PubMed ID: 17523078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers.
    Soria JC; Rodriguez M; Liu DD; Lee JJ; Hong WK; Mao L
    Cancer Res; 2002 Jan; 62(2):351-5. PubMed ID: 11809677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection?
    Kim YT; Lee SH; Sung SW; Kim JH
    Ann Thorac Surg; 2005 Apr; 79(4):1180-8; discussion 1180-8. PubMed ID: 15797047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG island methylation in premalignant stages of gastric carcinoma.
    Kang GH; Shim YH; Jung HY; Kim WH; Ro JY; Rhyu MG
    Cancer Res; 2001 Apr; 61(7):2847-51. PubMed ID: 11306456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
    Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M
    Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azacytidine inhibits the proliferation of human promyelocytic leukemia cells (HL60) by demethylation of MGMT, DAPK and p16 genes.
    Su Y; Xu H; Xu Y; Yu J; Xian Y; Luo Q
    Hematology; 2012 Jan; 17(1):41-6. PubMed ID: 22549447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation patterns of death-associated protein kinase and p16 genes in vulvar lichen sclerosus.
    Aidé S; Lattario FR; Almeida G; do Val IC; Carvalho Mda G
    J Low Genit Tract Dis; 2010 Oct; 14(4):282-6. PubMed ID: 20885153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DAPK1 promoter hypermethylaiton in brain metastases and peripheral blood.
    Martinez-Glez V; Franco-Hernandez C; Gonzalez-Gomez P; Isla A; De Campos JM; Vaquero J; Gutierrez M; Casartelli C; Rey JA
    Neoplasma; 2007; 54(2):123-6. PubMed ID: 17319784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive Melting Analysis after Real Time- Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection.
    Kristensen LS; Mikeska T; Krypuy M; Dobrovic A
    Nucleic Acids Res; 2008 Apr; 36(7):e42. PubMed ID: 18344521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
    Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
    Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.
    Jarmalaite S; Kannio A; Anttila S; Lazutka JR; Husgafvel-Pursiainen K
    Int J Cancer; 2003 Oct; 106(6):913-8. PubMed ID: 12918069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denaturing high-performance liquid chromatography (DHPLC) as a reliable high-throughput prescreening method for aberrant promoter methylation in cancer.
    Betz B; Florl AR; Seifert HH; Dall P; Schulz WA; Niederacher D
    Hum Mutat; 2004 Jun; 23(6):612-20. PubMed ID: 15146466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas.
    Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z
    Oral Oncol; 2011 Aug; 47(8):702-8. PubMed ID: 21697000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.